Dendritic Cell Vaccination in Treatment of Relapsed Pediatric AML
2 Mga view
• 07/04/23
0
0
I-embed
administrator
Mga subscriber
Despite allogeneic hematopoietic cell transplantation the survival chances in pediatric AML are 50% only. With the developed adjuvant WT1 Cord Blood Derived Dendritic Cell Vaccine the survival chances may increase. The clinical study will start early 2017.
PIs: Dr Jaap Jan Boelens (clinical / translational) and Dr Stefan Nierkens (lab / translational)
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento